Resources for coping with cancer during COVID-19. Learn More

Can we Really use Viruses to Treat Prostate Cancer?

Presenter: Dr. Jean-Simon Diallo
Original Date: Tuesday, April 5, 2016

Join Dr. Diallo to learn about: 

  • Basic cancer biology
  • Oncolytic virotherapy and oncolytic vaccines
  • Prostate cancer progression/treatment
  • How we are aiming to treat prostate cancer using our novel oncolytic vaccine approach

Dr. Jean-Simon Diallo's Biography:

Dr. Jean-Simon Diallo obtained his Master’s degree in Biochemistry at McGill University and his Ph.D in molecular biology at the Université de Montréal, where he studied natural compounds to treat prostate cancer and bio-markers to predict prostate cancer outcome. During his postdoctoral fellowship, Dr. Diallo worked on using oncolytic viruses to treat cancer and discovered a host of “viral sensitizer” molecules that enhance viral infection. Since 2012, he has been a Scientist at the Ottawa Hospital Research Institute. Working within a national network of collaborators, he and his team are working to improve virus-based therapeutics for the treatment of cancer and other diseases, by combining them with an increasing collection of novel “viral sensitizer” small molecules.

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive